Bioelectronics Corp (BIEL)

[Simpsonly]

Since I was not invested in BIEL when it rose to 12 cents, I am hungry for information comparing now to then and potential pps in preparation of an exit strategy.

I understand that, at the time, the CEO was perhaps saying too much to too many about the FDA process and potential approvals being soon and so on (i.e. inappropriate blah, blah syndrome), along with a PR man extolling the virtues of BIEL.

Up it went from around .004 to 12 cents over a period of a few months. Nothing from the FDA, no rejection, no appeal, no Senator Barbara Mikulski, no Inspector General, no bio-physicist, no meeting with 20 plus FDA people, no message from Paul stating BIEL had adequately addressed the new FDA issue of concern, all conditions we see now.

Here we are a few years and a lot of angst among shareholders later and waiting for FDA approval on ALLAY, which I don't think was prominent in 'approval soon' mode a few years ago and ActiPatch, which was. Casper supplied sound mathematics illustrating 12 cents then being same as 7.5 cents now, which is great for those in at under 1 But, my curiosity is specifically related to the ever elusive investor sentiments and pps now if FDA approval on ALLAY and ActiPatch evolve in the next 3 to 6 months. It would seem that, with either of those approvals occuring, BIEL will then be better positioned to do traditional retail drugstore deals with the majors in Canada and the US, notwithstanding that I think they should do any deal they can in Canada right now. Thanks to responders.